Cardiac Implantable Electronic Device
6
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Virtual Reality in Electrophysiological Procedures and Device Implantation: the VR inEP Trial
Efficiency of Electronic Multimedia Intervention With the Cardiac Implantable Electronic Device.
PECs for Implantable Cardiac Electronic Device Insertion
Biomarkers Predicting Atrial High Rate Episodes in Cardiac Implantable Electronic Device Recipients
DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)
Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli